Moving Medicine Forward

PureTech is led by a proven and seasoned management team. Collectively, they have overseen the research and development of products supporting 20 regulatory approvals and has been involved in the C-suite of companies acquired for more than $13 billion cumulatively.

Dennis Ausiello, MD
Board Advisor and R&D Committee Member
Miscellaneous Information:

Dennis Ausiello, MD is a member of the PureTech R&D Committee and Board Advisor. He is the Jackson Distinguished Professor of Clinical Medicine and Director, Emeritus of the MD/PhD Program at Harvard Medical School. Dr. Ausiello is Chairman of Medicine, Emeritus and Director of the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital (MGH). This center is a partnership among MGH, MIT, and Harvard University whose mission is to develop real-time assessment of human traits in wellness and disease. In partnership with industry, it is creating tools for measurements of traditional and novel phenotypes. A graduate of Harvard and the University of Pennsylvania, Dr. Ausiello is a nationally recognized leader in academic medicine who was elected to the National Academy of Medicine in 1999 and the American Academy of Arts and Sciences in 2003. He has published numerous articles, book chapters and textbooks and served as an editor of Cecil's Textbook of Medicine. Understanding the need for partnerships between the academy and industry, Dr. Ausiello serves on the Board of Directors of Pfizer Pharmaceuticals, where he was their former Lead Director. He also serves as a member of the Board of Directors of the microbiome company Seres Health, and the interference RNA company, Alnylam. Dr. Ausiello is also a member of the Board of Directors of several non-public biotech companies and is a consultant to Verily (formerly Google Life Sciences).

Share our vision, creativity & dedication - Join PureTech Health

Share our vision, creativity & dedication.

Join PureTech